ANDREW LEE was named medical director of the Texas Center for Proton Therapy, a collaboration of Texas Oncology, Baylor Health, McKesson Specialty Health, and The US Oncology Network, effective Feb. 1.
PELOTONIA awarded six, two-year grants to projects at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital & Richard J. Solove Research Institute.
MOUNT SINAI HEALTH SYSTEM and Valley Health System announced plans to collaborate on clinical programs, research and educational initiatives. Mount Sinai comprises seven hospitals and the Icahn School of Medicine at Mount Sinai. Valley Health System, headquartered in Ridgewood, N.J., includes The Valley Hospital, Valley Home Care and Valley Medical Group.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY and the College of American Pathologists announced a partnership to further inter-professional education, advocacy, quality improvement, international outreach, and practice guideline development. The two organizations signed a memorandum of understanding.
THE BARBARA ANN KARMANOS CANCER INSTITUTE received a grant of $5,375,000 from the Dresner Foundation. The grant, focused on hematologic malignancies research, will be distributed over the next five years.
ROCHE acquired Bina Technologies Inc., a privately held company that provides a big data platform for centralized management and processing of next generation sequencing data for the academic and translational research markets.
Dorothy “Dottie” Thomas, wife and research partner to 1990 Nobel laureate E. Donnall Thomas, died Jan. 9, at her home near Seattle. She was 92.
SETON HALL UNIVERSITY and Hackensack University Health Network announced plans to form a new, four-year school of medicine. The partnership will establish the only private school of medicine in New Jersey.
The Federation of American Societies for Experimental Biology called for a re-examination of the way research is funded in the U.S., in a report detailing the challenges facing researchers and the threats to continued progress in the field.
NAIYER RIZVI was named director of thoracic oncology and immunotherapeutics in medical oncology at NewYork-Presbyterian/Columbia University Medical Center. Rizvi comes from Memorial Sloan Kettering Cancer Center, where he was an attending physician and focused on thoracic immunotherapy.
